Prevail Therapeutics's activity chart (see below) currently has 20 price targets and 17 ratings on display.
Analysts' price targets on this stock were met 70.91% of the time, taking 191.45 days on average.
Most recent stock forecast was given by from WEDBUSH on 23-Dec-2020. First documented stock forecast 15-Jul-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Jul-2019
$22
$22
5 years 10 months 29 days ago
(23-Dec-2020)
2/5 (40%)
$-1.18 (-5.09%)
234
Buy Since 16-Jul-2020
$23
5 years 11 months 4 days ago
(17-Dec-2020)
2/2 (100%)
$-0.17 (-0.73%)
84
Buy Since 06-Mar-2020
$24
5 years 11 months 6 days ago
(15-Dec-2020)
0/2 (0%)
$1.25 (5.49%)
Buy Since 09-Apr-2020
$24.5
$20
5 years 11 months 6 days ago
(14-Dec-2020)
4/5 (80%)
$1.75 (7.69%)
206
Buy Since 15-Jul-2019
$20
$20
6 years 10 months 25 days ago
(27-Dec-2019)
2/2 (100%)
$4.19 (26.50%)
437
What is PRVL (Prevail Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on PRVL (Prevail Therapeutics)?
Which analyst has the most public recommendations on PRVL (Prevail Therapeutics)?
Which analyst is the currently most bullish on PRVL (Prevail Therapeutics)?
Which analyst is the currently most reserved on PRVL (Prevail Therapeutics)?